Matthew T David - Net Worth and Insider Trading

Matthew T David Net Worth

The estimated net worth of Matthew T David is at least $16,128 dollars as of 2024-05-27. Matthew T David is the Interim CEO and CFO of Cormedix Inc and owns about 3,150 shares of Cormedix Inc (CRMD) stock worth over $16,128. Details can be seen in Matthew T David's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew T David has not made any transactions after 2021-12-06 and currently still holds the listed stock(s).

Transaction Summary of Matthew T David

To

Matthew T David Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew T David owns 1 companies in total, including Cormedix Inc (CRMD) .

Click here to see the complete history of Matthew T David’s form 4 insider trades.

Insider Ownership Summary of Matthew T David

Ticker Comapny Transaction Date Type of Owner
CRMD Cormedix Inc 2021-12-06 EVP & Chief Financial Officer

Matthew T David Latest Holdings Summary

Matthew T David currently owns a total of 1 stock. Matthew T David owns 3,150 shares of Cormedix Inc (CRMD) as of December 6, 2021, with a value of $16,128.

Latest Holdings of Matthew T David

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRMD Cormedix Inc 2021-12-06 3,150 5.12 16,128

Holding Weightings of Matthew T David


Matthew T David Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew T David has made a total of 4 transactions in Cormedix Inc (CRMD) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Cormedix Inc is the acquisition of 1,000 shares on December 6, 2021, which cost Matthew T David around $4,500.

Insider Trading History of Matthew T David

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew T David Trading Performance

GuruFocus tracks the stock performance after each of Matthew T David's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew T David is 21.19%. GuruFocus also compares Matthew T David's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew T David within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew T David's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew T David

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.13
Relative Return to S&P 500(%) 11.13

Matthew T David Ownership Network

Ownership Network List of Matthew T David

No Data

Ownership Network Relation of Matthew T David


Matthew T David Owned Company Details

What does Cormedix Inc do?

Who are the key executives at Cormedix Inc?

Matthew T David is the EVP & Chief Financial Officer of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Head of Clinical Ops. Elizabeth Masson .

Cormedix Inc (CRMD) Insider Trades Summary

Over the past 18 months, Matthew T David made no insider transaction in Cormedix Inc (CRMD). Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 28,561 shares made by Joseph Todisco , a net purchase of 9,000 shares made by Alan W Dunton , and a net purchase of 10,000 shares made by Paulo F Costa .

In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 13,561 shares, with a net purchase of 13,561 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 64,561 shares were bought by its insiders, resulting in a net purchase of 64,561 shares.

Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cormedix Inc Insider Transactions

No Available Data

Matthew T David Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew T David. You might contact Matthew T David via mailing address: 300 Connell Drive, Suite 4200, Berkeley Heights Nj 07922.

Discussions on Matthew T David

No discussions yet.